Exposure to Air Pollutants and Lewy Body and Parkinson Disease–Related Dementias - Top-Institutions - MDSpire

Exposure to Air Pollutants and Lewy Body and Parkinson Disease–Related Dementias

  • By

  • Dimitry S. Davydow

  • Gregory M. Pontone

  • Michael S. Okun

  • Melissa J. Armstrong

  • Theresa Wimberley Böttger

  • Camila Geels

  • Lise Marie Frohn

  • Jørgen Brandt

  • Julie Werenberg Dreier

  • Jakob Christensen

  • Carsten Bøcker Pedersen

  • Henriette Thisted Horsdal

  • May 14, 2026

  • 0 min

Share

Top Institutions in Neurology

Brief introduction explaining scope and methodology.

  • #1

    University of Florida
    University of Florida

    Gainesville, Florida

    Key Differentiators

    • Neurology

  • #2

    Danish National Patient Register
    Danish National Patient Register

    Copenhagen, Denmark

    Key Differentiators

    • Neurology

  • #3

    Danish Central Psychiatric Research Register
    Danish Central Psychiatric Research Register

    Copenhagen, Denmark

    Key Differentiators

    • Neurology

  • #4

    Mayo Clinic
    Mayo Clinic

    Jacksonville, Florida

    Key Differentiators

    • Neurology

  • #5

    Alzheimer’s Disease Neuroimaging Initiative
    Alzheimer’s Disease Neuroimaging Initiative

    Los Angeles, California

    Key Differentiators

    • Neurology

Original Source(s)

Exposure to Air Pollutants and Lewy Body and Parkinson Disease–Related Dementias

  • by Dimitry S. Davydow, Gregory M. Pontone, Michael S. Okun, Melissa J. Armstrong, Theresa Wimberley Böttger, Camila Geels, Lise Marie Frohn, Jørgen Brandt, Julie Werenberg Dreier, Jakob Christensen, Carsten Bøcker Pedersen, Henriette Thisted Horsdal

  • May 14, 2026

Related Content

Evaluating impulse control disorders in people with Parkinson’s disease: agreement and added value of patient and caregiver reports

A multimodal machine learning model for predicting postoperative worsening of FOGQ in Parkinson’s disease following STN-DBS

This Week’s CGT News: Novo’s Parkinson’s Pivot

Novo Nordisk’s Parkinson’s cell therapy finds a new home at Cellular Intelligence, while base editing, prime editing, and large-insertion genome writing push forward

  • May 18, 2026

  • 7 min